MediPharm Labs Corp (MEDIF)
0.0619
0.00 (0.00%)
USD |
OTCM |
May 17, 15:11
MediPharm Labs Profit Margin (Quarterly): -32.47% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -32.47% |
| September 30, 2023 | -50.88% |
| June 30, 2023 | -28.21% |
| March 31, 2023 | -52.85% |
| December 31, 2022 | -99.88% |
| September 30, 2022 | -109.2% |
| June 30, 2022 | -206.0% |
| March 31, 2022 | -152.9% |
| December 31, 2021 | -379.0% |
| September 30, 2021 | -136.2% |
| Date | Value |
|---|---|
| June 30, 2021 | -232.9% |
| March 31, 2021 | -252.4% |
| December 31, 2020 | -510.9% |
| September 30, 2020 | -302.4% |
| June 30, 2020 | -24.10% |
| March 31, 2020 | -154.1% |
| December 31, 2019 | -9.92% |
| September 30, 2019 | 7.78% |
| June 30, 2019 | 6.35% |
| March 31, 2019 | -2.32% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-510.9%
Minimum
Dec 2020
7.78%
Maximum
Sep 2019
-143.2%
Average
-109.2%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
| Venus Concept Inc | -61.31% |
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | -59.60% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -448.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -23.52% |
| Return on Assets | -19.56% |
| Return on Invested Capital | -22.87% |
| Gross Profit Margin (Quarterly) | 24.05% |
| Operating Margin (Quarterly) | -26.61% |
| Return on Net Operating Assets | -28.26% |